JP2023511184A5 - - Google Patents

Info

Publication number
JP2023511184A5
JP2023511184A5 JP2022544413A JP2022544413A JP2023511184A5 JP 2023511184 A5 JP2023511184 A5 JP 2023511184A5 JP 2022544413 A JP2022544413 A JP 2022544413A JP 2022544413 A JP2022544413 A JP 2022544413A JP 2023511184 A5 JP2023511184 A5 JP 2023511184A5
Authority
JP
Japan
Prior art keywords
compound according
val
cit
gly
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022544413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023511184A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/051259 external-priority patent/WO2021148500A1/en
Publication of JP2023511184A publication Critical patent/JP2023511184A/ja
Publication of JP2023511184A5 publication Critical patent/JP2023511184A5/ja
Pending legal-status Critical Current

Links

JP2022544413A 2020-01-22 2021-01-21 化合物及びその複合体 Pending JP2023511184A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062964181P 2020-01-22 2020-01-22
US62/964,181 2020-01-22
PCT/EP2021/051259 WO2021148500A1 (en) 2020-01-22 2021-01-21 Compounds and conjugates thereof

Publications (2)

Publication Number Publication Date
JP2023511184A JP2023511184A (ja) 2023-03-16
JP2023511184A5 true JP2023511184A5 (cg-RX-API-DMAC7.html) 2024-01-30

Family

ID=74494865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544413A Pending JP2023511184A (ja) 2020-01-22 2021-01-21 化合物及びその複合体

Country Status (10)

Country Link
US (1) US20230097908A1 (cg-RX-API-DMAC7.html)
EP (1) EP4093439A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023511184A (cg-RX-API-DMAC7.html)
KR (1) KR20220130749A (cg-RX-API-DMAC7.html)
CN (1) CN114980934A (cg-RX-API-DMAC7.html)
AU (1) AU2021210570A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022014391A2 (cg-RX-API-DMAC7.html)
CA (1) CA3166732A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022009052A (cg-RX-API-DMAC7.html)
WO (1) WO2021148500A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118414339A (zh) * 2021-12-16 2024-07-30 迈威(上海)生物科技股份有限公司 一种喜树碱类化合物及其偶联物
AU2023279443A1 (en) 2022-06-03 2025-01-23 Ube Corporation Antibody-multidrug conjugate
CN115160403B (zh) * 2022-07-05 2025-06-27 博石丰生命科技(南通)有限公司 特异性拓扑异构酶抑制剂和可用于抗体药物偶联物及其制备方法
WO2026078165A1 (en) 2024-10-10 2026-04-16 Astrazeneca Ab Conjugates comprising cleavable linkers
WO2026145631A1 (zh) * 2024-12-31 2026-07-09 上海复宏汉霖生物技术股份有限公司 一种配体-药物偶联物及制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
JP2540357B2 (ja) * 1987-06-24 1996-10-02 第一製薬株式会社 六環性化合物
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
NZ567140A (en) 2005-10-07 2011-09-30 Exelixis Inc Azetidines as MEK inhibitors for the treatment of proliferative diseases
DK1813614T3 (da) 2006-01-25 2012-01-23 Sanofi Sa Cytotoksiske midler, der omfatter nye tomaymycinderivater
JP5394246B2 (ja) * 2007-03-30 2014-01-22 ジェネンテック, インコーポレイテッド 抗体及びイムノコンジュゲートとこれらの使用方法
PE20090245A1 (es) 2007-05-08 2009-03-17 Genentech Inc Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos
BRPI0818780A2 (pt) 2007-10-19 2015-04-22 Genentech Inc Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos
EA201200486A1 (ru) * 2009-09-15 2012-08-30 Серулин Фарма Инк. Лечение онкологических заболеваний
TWI871999B (zh) * 2014-04-10 2025-02-01 日商第一三共股份有限公司 抗her3抗體-藥物結合物
HUE067016T2 (hu) * 2015-11-25 2024-09-28 Ligachem Biosciences Inc Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
US20190367605A1 (en) 2016-11-10 2019-12-05 Medimmune, Llc Binding Molecules Specific For ASCT2 And Uses Thereof
JP7244987B2 (ja) * 2016-12-14 2023-03-23 シージェン インコーポレイテッド 多剤抗体薬物コンジュゲート
KR20200142525A (ko) * 2018-04-05 2020-12-22 노파르티스 아게 암에 대한 삼중특이성 결합 분자 및 이의 용도
EP3794042B1 (en) * 2018-05-18 2024-03-27 Daiichi Sankyo Co., Ltd. Anti-muc1- exatecan antibody-drug conjugate
KR20240104214A (ko) * 2019-03-29 2024-07-04 메디뮨 리미티드 화합물 및 이의 접합체
CN110974975B (zh) * 2019-12-12 2023-10-20 成都百利多特生物药业有限责任公司 一种快速释放的抗体药物偶联物
US12605459B2 (en) * 2020-07-13 2026-04-21 Regeneron Pharmaceuticals, Inc. Protein-drug conjugates comprising camptothecin analogs and methods of use thereof
NL2026947B1 (en) * 2020-11-20 2022-07-01 Synaffix Bv Tyrosine-based antibody conjugates

Similar Documents

Publication Publication Date Title
JP6937090B2 (ja) 免疫調節剤としての1,2,4−オキサジアゾールおよびチアジアゾール化合物
CN108164474B (zh) 作为免疫调节剂的1,2,4-二唑衍生物
JP2022528851A5 (cg-RX-API-DMAC7.html)
JP2023512501A5 (cg-RX-API-DMAC7.html)
JP2023018157A (ja) 親水性抗体-薬物コンジュゲート
US9096642B2 (en) Therapeutic compounds for immunomodulation
CN1113066C (zh) 新型肽衍生物
JP3970317B2 (ja) 酵素インヒビター
AU2018271235A1 (en) Cyclic peptidomimetic compounds as immunomodulators
KR20170123680A (ko) 면역조절제로서의 1,3,4-옥사다이아졸 및 티아다이아졸 화합물
KR20170125931A (ko) 면역조절제로서의 3-치환된 1,3,4-옥사다이아졸 및 티아다이아졸 화합물
DE69223266T2 (de) Peptidderivate und deren Verwendung
HUE035463T2 (hu) Citotoxikus peptidek és ezek antitest-hatóanyag konjugátumai
KR20160081898A (ko) 면역조절제로서 1,3,4-옥사디아졸 및 1,3,4-티아디아졸 유도체
CN107849090A (zh) 抗体药物偶联物
WO2025040047A1 (zh) 抗体偶联药物、其制备方法及应用
AU744425B2 (en) 20(s) camptothecin glycoconjugates
JP2020189806A (ja) 複合体
JP5393482B2 (ja) 抗癌活性を有するテトラサイクリン・アントラキノン系化合物
JP2022519002A (ja) 酸法による抗体薬物複合体中間体の調製方法及びその応用
CN101077885A (zh) 新型抗肿瘤化合物
HUT75538A (en) Oligopeptides derived from c-reactive protein fragments
CN102875651B (zh) 抗肿瘤靶向激活的多肽阿霉素、其制备方法和用途
CN101153053B (zh) 骨生肽、其制备方法和其药物组合物与用途
BRPI0621664A2 (pt) conjugado de interferon alfa com polietileno glicol